QQQ   358.51 (+1.01%)
AAPL   173.02 (+0.36%)
MSFT   318.36 (+1.59%)
META   304.14 (+1.06%)
GOOGL   135.00 (+1.94%)
AMZN   125.98 (+1.01%)
TSLA   255.88 (+3.79%)
NVDA   439.51 (+1.00%)
NIO   8.74 (+1.51%)
BABA   84.22 (-0.38%)
AMD   102.39 (+2.31%)
T   14.54 (-1.62%)
F   12.05 (-0.17%)
MU   67.84 (+0.01%)
CGC   0.74 (+7.73%)
GE   108.64 (+0.82%)
DIS   79.29 (-0.31%)
AMC   8.03 (+2.29%)
PFE   33.66 (-0.71%)
PYPL   58.24 (+1.64%)
NFLX   377.39 (+0.17%)
QQQ   358.51 (+1.01%)
AAPL   173.02 (+0.36%)
MSFT   318.36 (+1.59%)
META   304.14 (+1.06%)
GOOGL   135.00 (+1.94%)
AMZN   125.98 (+1.01%)
TSLA   255.88 (+3.79%)
NVDA   439.51 (+1.00%)
NIO   8.74 (+1.51%)
BABA   84.22 (-0.38%)
AMD   102.39 (+2.31%)
T   14.54 (-1.62%)
F   12.05 (-0.17%)
MU   67.84 (+0.01%)
CGC   0.74 (+7.73%)
GE   108.64 (+0.82%)
DIS   79.29 (-0.31%)
AMC   8.03 (+2.29%)
PFE   33.66 (-0.71%)
PYPL   58.24 (+1.64%)
NFLX   377.39 (+0.17%)
QQQ   358.51 (+1.01%)
AAPL   173.02 (+0.36%)
MSFT   318.36 (+1.59%)
META   304.14 (+1.06%)
GOOGL   135.00 (+1.94%)
AMZN   125.98 (+1.01%)
TSLA   255.88 (+3.79%)
NVDA   439.51 (+1.00%)
NIO   8.74 (+1.51%)
BABA   84.22 (-0.38%)
AMD   102.39 (+2.31%)
T   14.54 (-1.62%)
F   12.05 (-0.17%)
MU   67.84 (+0.01%)
CGC   0.74 (+7.73%)
GE   108.64 (+0.82%)
DIS   79.29 (-0.31%)
AMC   8.03 (+2.29%)
PFE   33.66 (-0.71%)
PYPL   58.24 (+1.64%)
NFLX   377.39 (+0.17%)
QQQ   358.51 (+1.01%)
AAPL   173.02 (+0.36%)
MSFT   318.36 (+1.59%)
META   304.14 (+1.06%)
GOOGL   135.00 (+1.94%)
AMZN   125.98 (+1.01%)
TSLA   255.88 (+3.79%)
NVDA   439.51 (+1.00%)
NIO   8.74 (+1.51%)
BABA   84.22 (-0.38%)
AMD   102.39 (+2.31%)
T   14.54 (-1.62%)
F   12.05 (-0.17%)
MU   67.84 (+0.01%)
CGC   0.74 (+7.73%)
GE   108.64 (+0.82%)
DIS   79.29 (-0.31%)
AMC   8.03 (+2.29%)
PFE   33.66 (-0.71%)
PYPL   58.24 (+1.64%)
NFLX   377.39 (+0.17%)
NYSE:CNC

Centene (CNC) Price Target & Analyst Ratings

$68.32
+0.08 (+0.12%)
(As of 11:51 AM ET)
Compare
Today's Range
$67.77
$68.51
50-Day Range
$61.26
$70.58
52-Week Range
$60.83
$87.84
Volume
378,195 shs
Average Volume
3.54 million shs
Market Capitalization
$36.99 billion
P/E Ratio
14.09
Dividend Yield
N/A
Price Target
$83.35

Centene Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 14 Analyst Ratings

Consensus Analyst Price Target

$83.35
22.00% Upside
High Prediction$110.00
Average Prediction$83.35
Low Prediction$71.00
TypeCurrent
10/4/22 to 10/4/23
1 Month Ago
9/4/22 to 9/4/23
3 Months Ago
7/6/22 to 7/6/23
1 Year Ago
10/4/21 to 10/4/22
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
10 Buy rating(s)
13 Buy rating(s)
Hold
9 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$83.35$84.94$88.68$97.85
Predicted Upside22.00% Upside20.28% Upside19.17% Upside17.33% Upside
Get Centene Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.


CNC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Centene Stock vs. The Competition

TypeCenteneMedical CompaniesS&P 500
Consensus Rating Score
2.36
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside22.15% Upside869.41% Upside701.34% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/14/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$82.00+21.34%
9/5/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$79.00 ➝ $72.00+17.51%
8/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$94.00 ➝ $73.00+13.28%
7/31/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$110.00+60.72%
7/31/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$87.00 ➝ $85.00+28.44%
7/31/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$86.00 ➝ $85.00+28.44%
7/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform
7/11/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$80.00 ➝ $76.00+12.91%
7/7/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$81.00 ➝ $77.00+14.63%
6/20/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$88.00 ➝ $83.00+26.41%
6/20/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$72.00+9.66%
4/26/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$94.00 ➝ $87.00+25.56%
3/21/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$79.00 ➝ $71.00+10.68%
3/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$94.00 ➝ $79.00+16.26%
2/14/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$101.00 ➝ $97.00+32.73%
2/8/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$97.00 ➝ $74.00+2.91%
2/8/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$110.00 ➝ $95.00+33.84%
12/14/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$95.00 ➝ $99.00+18.96%
(Data available from 10/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CNC Price Target - Frequently Asked Questions

What is Centene's consensus rating and price target?

According to the issued ratings of 14 analysts in the last year, the consensus rating for Centene stock is Hold based on the current 9 hold ratings and 5 buy ratings for CNC. The average twelve-month price prediction for Centene is $83.35 with a high price target of $110.00 and a low price target of $71.00. Learn more on CNC's analyst rating history.

Do Wall Street analysts like Centene more than its competitors?

Analysts like Centene less than other Medical companies. The consensus rating for Centene is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how CNC compares to other companies.

Is Centene being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Centene's stock had 2 downgrades and 1 upgrade by analysts.

Does Centene's stock price have much upside?

According to analysts, Centene's stock has a predicted upside of 21.69% based on their 12-month price targets.

What analysts cover Centene?

Stock Ratings Reports and Tools

This page (NYSE:CNC) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -